Abstract
Alpha-interferon has emerged as the most effective agent for the treatment of chronic hepatitis when active replication of virus B, C, or D is present. Exogenous administration of human alpha-interferon, now possible through modern large-scale production methods, is associated with suppression of virus in blood. Amelioration of liver disease occurs in 35% of patients with hepatitis B virus and in 50% with hepatitis C virus with interferon doses of 30 and 10 MU per week, respectively, for 16-26 weeks; after therapy, persistent normalization of serum alanine aminotransferase is observed in 35% and 27%, respectively. Similar results have now also been reported for chronic hepatitis D. Enhanced response rates (greater than 50%) may be obtained by prolonged intermittent interferon therapy. Combination of interferon with another 'antiviral' agent (vidarabine, acyclovir, prednisone) has not increased therapeutic efficacy. Alpha-interferon induces side effects such as fatigue, flu-like syndrome, myalgia, and changes in mood and granulocytes. Patients with decompensated cirrhosis are particularly prone to bacterial infection and disease exacerbation and should receive lower doses. Interferon, when applied skillfully, induces the highly ...Continue Reading
References
Oct 1, 1976·Gut·S W SchalmL R Elveback
Sep 2, 1976·The New England Journal of Medicine·H B GreenbergT C Merigan
Mar 31, 1990·Lancet·I G McFarlaneR Williams
Mar 7, 1987·Lancet·B J ThomsonA D Webster
Sep 1, 1987·Annals of Internal Medicine·G GarciaK Waterman
Jan 14, 1989·BMJ : British Medical Journal·M R JacynaH C Thomas
Apr 21, 1989·Science·G KuoC E Stevens
Nov 30, 1989·The New England Journal of Medicine·G L DavisUNKNOWN Hepatitis Interventional Therapy Group
Nov 30, 1989·The New England Journal of Medicine·A M Di BisceglieJ H Hoofnagle
Nov 1, 1989·Seminars in Liver Disease·J H Hoofnagle, A M Di Bisceglie
Sep 9, 1989·Lancet·W F CarmanH C Thomas
May 18, 1985·Lancet·I S FentimanJ L Hayward
Aug 17, 1985·Lancet·S W SchalmR A de Man
Jul 11, 1987·Lancet·G J AlexanderR Williams
Dec 18, 1986·The New England Journal of Medicine·J H HoofnagleE A Jones
Jul 15, 1988·Annals of Internal Medicine·R P PerrilloM C Kuhns
Jul 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J H HoofnagleH Popper
Nov 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A SmedileJ L Gerin
Feb 16, 1980·Lancet·W WeimarK Cantell
May 1, 1983·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J ScottoC Brechot
Feb 12, 1981·The New England Journal of Medicine·K C LamP C Wu
Citations
Jan 6, 1999·The Journal of Pathology·S C AffordD H Adams
May 1, 1994·Scandinavian Journal of Gastroenterology·J Wu, A Danielsson
Jan 1, 1990·Scandinavian Journal of Gastroenterology. Supplement·C B Lamers